# Trialbee

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/trialbee

- Industry: Healthcare IT
- Headquarters: Malmo, Sweden
- Website: www.trialbee.com
- Total disclosed funding: $5M
- Latest round: Series A (May 21, 2015)
- Investors on record: 1

## About

Trialbee AB is a clinical trial technology company that streamlines patient recruitment through its innovative Honey Platform™, enhancing efficiency and transparency in the recruitment process.Founded in 2010 in Malmo, Sweden, Trialbee AB specializes in patient recruitment solutions for clinical trials. The company has raised EUR 11 million in venture funding, with its latest funding round occurring on April 28, 2020, backed by investors such as MTIP and Briban Invest. CEO Matt Walz leads the firm, which has completed a total of 5 deals to date.Trialbee specializes in streamlining patient recruitment for clinical trials through its flagship product, the Honey Platform™, which centralizes recruitment processes with a focus on transparency and efficiency. The platform leverages data-driven patient profile modeling, live medical secondary screening, and hyper-targeted digital outreach to connect researchers with ideal patients, ensuring that trials can meet enrollment targets effectively. Furthermore, Trialbee offers omnichannel solutions that engage patients at various stages of their healthcare journeys, utilizing a curated ecosystem of partners to enhance recruitment strategies. The company's clientele includes pharmaceutical companies, clinical research organizations, and healthcare providers across North America and Europe, where its services address critical challenges such as recruitment gaps and patient accessibility in clinical research.In 2022, Trialbee reported a revenue of EUR 5,348,351.10 with an EBITDA of EUR -5,223,757 for the same year. The company generates revenue through a subscription-based model and long-term contracts for access to its Honey Platform™, alongside services like precision recruitment and analytics reporting, serving primarily pharmaceutical firms and clinical trial sponsors.Following its recent funding round of EUR 11 million in April 2020, Trialbee plans to enhance its Honey Platform™ with new products aimed at improving patient engagement and recruitment efficiency. The company is also targeting expansion into new markets in Europe and North America by 2025, with the funding aimed at supporting these initiatives and scaling operations.

## Funding rounds

- Series A, May 21, 2015, $5M — Industrifonden

## Investors

- Industrifonden (https://capitalatlas.ai/funds/industrifonden) — Series A